Our previous studies indicated that blood myeloid cells from healthy donors did not express intracellular IL-17A or BCL2A1, while IL-17A was expressed in blood myeloid cells from LCH patients (8, 29, 34, 35). This evidence concerns the gene BCL2A1 and Langerhans cell histiocytosis.